Status:
NOT_YET_RECRUITING
Canadian Adult Congenital Heart Disease Intervention Registry
Lead Sponsor:
University Health Network, Toronto
Conditions:
Atrial Septal Defect
Patent Foramen Ovale
Eligibility:
All Genders
18-110 years
Brief Summary
The ACHDi Registry study will create a foundational database for adult congenital heart disease interventions. This Pan-Canadian Registry will collect clinical and patient-reported information that wi...
Detailed Description
The goal of this study is to establish a rigorously developed registry to enable an impactful research agenda in adults with congenital heart disease interventions (ACHDi). The clinical and patient-re...
Eligibility Criteria
Inclusion
- participants must be 18 years or older referred for intervention for one of five ACHD conditions including diagnostic catheterization for complex ACHD patients (Tetralogy of Fallot, Fontan, and transposition of the great vessels, single ventricle, truncus arteriosus); transcatheter closure of atrial septal defects; transcatheter closure of patent foramen ovale; coarctation of aorta stenting, and percutaneous pulmonary valve implantation.
Exclusion
- participants below the age of 18
- participants residing outside of Canada
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2030
Estimated Enrollment :
9000 Patients enrolled
Trial Details
Trial ID
NCT04288596
Start Date
April 1 2020
End Date
April 1 2030
Last Update
February 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto General Hospital
Toronto, Ontario, Canada, M5G 2C4